C12N 2760/18262
By genetic engineering
Official title: by genetic engineering
C12N2760/18262 (By genetic engineering) appears on 1 US grants and 2 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 2
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 22 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Nipah henipavirus virus replicon particles and their use27 Feb 2025US 2025/0064918 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Tunable vaccine platform against pathogens of the paramyxovirus family15 Nov 2018US 2018/0326046 A1Georgia State University Reseach Foundation, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.